Subacromial Impingement SyndromeNCT05071469
Comparison of Two Different Treatment Methods
A study testing Kinesiotaping and Mulligan Mobilization Technique in people with Subacromial Impingement Syndrome and Musculoskeletal Diseases, run by Banu BAYAR at 1 site in Turkey (Türkiye).
Trial summary
A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS). Read more about this study
- Who is it for?
- Ages 35 to 65 years
- Conditions the study is for
- Subacromial Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Injury
- What is being tested?
- Kinesiotaping and Mulligan Mobilization Technique
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 28 Sep 2021to 30 Nov 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Impingement symptoms in clinical tests
- Pain >1 month
Who cannot join
- Any shoulder pathology.
- Have chronic systemic diseases or infections.
- History of any surgery shoulder complex.
- steroid injections and therapeutic approaches
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparison of Short-term Effects of Two Different Treatment Methods in Patients With Subacromial Impingement Syndrome: a Randomized Controlled Single-blind Trial
A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).
Read the detailed description
Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.
- Conditions
- Subacromial Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Injury, Musculoskeletal Pain, Weakness, Muscle
- Being tested
- Kinesiotaping, Mulligan Mobilization Technique
- Keywords
- Subacromial Impingement Syndrome, Mulligan Mobilization Technique, Kinesiotaping, Physiotherapy
- Medical subject headings
- Shoulder Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Pain, Muscle Weakness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KinesiotapingOther
KT was applied.
Mulligan Mobilization TechniqueOther
MMT was applied
| Study group | Role | What they receive |
|---|---|---|
| Control Group (CG) | No intervention | Control group |
| Kinesiotaping Group (KG) | Experimental | Experimental group Receives: Other: Kinesiotaping |
| Mulligan Mobilization Technique Group (MG) | Experimental | Experimental group (2) Receives: Other: Mulligan Mobilization Technique |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change of pain severity
Via VAS.
Measured: Baseline- after 2 weeks (after treatment)
Change of Range of Motion
Via goniometer.
Measured: Baseline- after 2 weeks (after treatment)
Change of Functionality
Via SPADI.
Measured: Baseline- after 2 weeks (after treatment)
Secondary outcomes (3)
Change of Sleep Quality
Via VAS.
Measured: Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Life
Via SWLS.
Measured: Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Treatment
Via VAs.
Measured: Baseline- after 2 weeks (after treatment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2021
- Study start28 Sep 2021
- Primary completion15 Oct 2021
- Study completion30 Nov 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Subacromial Impingement SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Controlled Trial
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Banu BAYAR
- Sponsor type
- University, hospital or other
- Collaborators
- Muğla Sıtkı Koçman University
- Responsible party
- Sponsor-investigator, Banu BAYAR, Muğla Sıtkı Koçman University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05071469
- Sponsor's protocol ID
- 180030/16
- Status last verified
- Dec 2022
- First submitted
- 28 Sep 2021
- Last updated
- 21 Dec 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Short-term Effects of Two Different Treatment Methods in Patients With Subacromial Impingement Syndrome: a Randomized Controlled Single-blind Trial
- ClinicalTrials.gov ID
- NCT05071469
- Acronym / sponsor ID
- 180030/16
- Conditions
- Subacromial Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Injury, Musculoskeletal Pain, Weakness, Muscle
- Keywords
- Subacromial Impingement Syndrome, Mulligan Mobilization Technique, Kinesiotaping, Physiotherapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Banu BAYARUniversity, hospital or other
- Collaborators
- Muğla Sıtkı Koçman University
- Study start
- 28 Sep 2021 (actual)
- Primary completion
- 15 Oct 2021 (actual)
- Study completion
- 30 Nov 2021 (actual)
- First posted
- 8 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).
Detailed description
Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
- Model description
- Randomized Controlled Trial
| Arm | Type | Receives |
|---|---|---|
| Control Group (CG) | No intervention | –Control group |
| Kinesiotaping Group (KG) | Experimental | Other: KinesiotapingExperimental group |
| Mulligan Mobilization Technique Group (MG) | Experimental | Other: Mulligan Mobilization TechniqueExperimental group (2) |
Who may qualify
- Ages
- 35 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Impingement symptoms in clinical tests
- Pain >1 month
Key exclusion criteria (4 listed)
- Any shoulder pathology.
- Have chronic systemic diseases or infections.
- History of any surgery shoulder complex.
- steroid injections and therapeutic approaches
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KinesiotapingKT was applied. | Other | Kinesiotaping Group (KG) |
| Mulligan Mobilization TechniqueMMT was applied | Other | Mulligan Mobilization Technique Group (MG) |
Primary outcome
Change of pain severity
Time frame: Baseline- after 2 weeks (after treatment)
Via VAS.
Change of Range of Motion
Time frame: Baseline- after 2 weeks (after treatment)
Via goniometer.
Change of Functionality
Time frame: Baseline- after 2 weeks (after treatment)
Via SPADI.
3 secondary outcomes
Change of Sleep Quality
Time frame: Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Life
Time frame: Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Treatment
Time frame: Baseline- after 2 weeks (after treatment)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Dec 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Subacromial Impingement Syndrome
Not yet recruiting
Effects of Different Kinesio Taping Methods in Subacromial Impingement Syndrome
Subacromial Impingement Syndrome
RecruitingObservational study
Pain Phenotype and Response to Corticosteroid Injection in Patients With Subacromial Pain Syndrome (SAPS)
Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain
RecruitingObservational study
Nociplastic Pain in Patients Diagnosed With Subacromial Pain Syndrome (SAPS)
Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain
RecruitingObservational study
Acromial Morphology: Reliability of CT-based Assessment and Relationship With Age in a Series of 420 Patients
Shoulder Impingement Syndrome, Acromial Morphology
Recruiting
Latissimus Dorsi Strengthening Exercises in Rotator Cuff Tendinopathy
Rotator Cuff Related Shoulder Pain, Rotator Cuff Tendinopathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesiotaping and Mulligan Mobilization Technique in people with Subacromial Impingement Syndrome and Musculoskeletal Diseases, run by Banu BAYAR at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change of pain severity (time frame: Baseline- after 2 weeks (after treatment)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2022.